PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 11, 2025Cancer Research3 citations

Comprehensive Multi-Omic Characterization of Perineural Invasion in Cervical Cancer Reveals Diagnostic Markers, Molecular Drivers, and Therapeutic Strategies

View Full Paper
TWTing WanTDTing DengXPXinxin Peng

Key Points

  • This research aims to elucidate the molecular mechanisms and potential diagnostic and therapeutic strategies related to perineural invasion in cervical cancer.
  • Generated whole-exome, whole-genome, and RNA-sequencing data from tumors and matched normal samples of cervical cancer patients.
  • Performed comparative analysis between perineural invasion and non-perineural invasion tumors.
  • Utilized a machine learning approach to identify gene expression signatures predictive of tumor PNI status.
  • Identified three-gene expression signature (MT1G, NPAS1, SPRY1) that predicts PNI status with high accuracy.
  • FBXW7 mutations linked to PNI identified as driver events leading to increased MYC activity.
  • OTX015, a BET inhibitor, revealed as a promising treatment for PNI tumors.

Abstract

Abstract Perineural invasion (PNI) is an important pathological feature of cervical cancer that is associated with poor prognosis and provides key information for clinical decisions. A better understanding of the molecular mechanisms underlying PNI could lead to improved patient treatment strategies. Here, we generated whole-exome, whole-genome, and RNA-sequencing data from tumors and matched normal clinical samples of 45 cervical cancer patients and performed a comparative analysis between 23 PNI and 22 non-PNI tumors. A robust machine learning approach identified a three-gene expression signature of MT1G, NPAS1, and SPRY1 that could predict the tumor PNI status with high accuracy, which was validated using an independent cohort (18 PNI and 19 non-PNI). Loss-of-function FBXW7 mutations were identified as driver events for PNI that lead to increased MYC activity and an immunosuppressive tumor microenvironment. Finally, a deep-learning model for predicting the drug efficacy over patients’ transcriptomic data revealed OTX015, a BET inhibitor, as a promising treatment that targets mutated FBXW7 PNI tumors. This study provides a rich resource for elucidating the molecular mechanisms of PNI tumors, laying a critical foundation for developing effective diagnostic and therapeutic strategies for PNI tumors in cervical cancer.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wan et al. (2025) studied this question.

synapsesocial.com/papers/69401b1e2d562116f28f7557https://doi.org/10.1158/0008-5472.can-25-0149
Ask AI
Helpful
Bookmark
Share
View Full Paper